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ABSTRACT 
Objective: We seek to investigate socio-economic differences in psychiatric in-patient care 
regarding admission, treatment and outcome. Method: This study is undertaken on a 
comprehensive and exhaustive psychiatric case register of all psychiatric in-patient care carried 
out in Belgium in 1997 and 1998 (n ¼ 144 754). Results: Lower socio-economic groups were 
more likely to be compulsorily admitted, to be cared for in a non-teaching or psychiatric 
hospital, to be admitted in a hospital with unexpectedly long average length of stay and to be 
admitted to a ward with a more severe casemix. They were less likely to receive antidepressants 
and psychotherapies. The improvements in functioning and in symptoms were also less 
favourable for these groups. The lowest group had a higher risk of dying in the hospital. 
Conclusion: Psychiatric in-patient care is associated with moderate socio-economic differences 
in access, treatment and outcome. Further research is needed to clarify the causes of such 
disparities. 
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The relationship between social class and mental disorder has been a longstanding issue in 
social psychiatry and psychiatric epidemiology (1, 2). Research has repeatedly shown a higher 
prevalence of mental disorders in the lower socio-economic groups. This socio-economic mental 
health gradient has been found in large-population epidemiological studies using psychiatric 
diagnostic instruments (3–5) or symptom checklists (6, 7). Although mental disorders remain 
largely untreated both in North America and Europe, several studies have evidenced few socio-
economic inequalities in mental care among subjects with psychiatric disorders (8). 
Most previous studies addressing inequalities in mental care have assumed that a fair 
distribution of care is achieved when individuals of equal ill-health status use the same quantity 
of care, disregarding differences in quality of care and disparities in outcome (9). As far as 
mental health is concerned, however, there is some evidence of unequal quality and outcome of 
care. Lower socioeconomic groups use less specialized care (8), while medication use and 
dosage are also less appropriate in such groups (10). In addition, some population studies have 
shown that poverty and low socio-economic status (SES) increase the duration of episodes for a 
given baseline clinical status (11, 12). Among these small patient studies, some have evidenced 
poorer clinical course for low educational groups (13, 14).  
There have also been some studies addressing socio-economic differences in out-patient or 
primary care (8, 15–19). But very few have addressed differences within in-patient psychiatric 
wards. Several pieces of research have attempted to predict the length of stay (20, 21). Others 
have evidenced a higher rate of psychiatric admission for individuals of low SES (22) or living in 
deprived areas (23, 24). Very few studies have addressed socio-economic disparities in 
admission, treatment and outcome of psychiatric in-patient care (22, 25).  
Overall access to care in Belgium is relatively good. Social security grants 96.9% of the 
population with a health care insurance, an out-of-pocket health care expenditure share of15% 
in average (26). It also has a high supply of general practitioners (GPs) and psychiatrists in the 
curative sector (respectively, 11.6 and 2.0 full-time equivalent per 10 000 inhabitants). There is 
no referral gateway to the psychiatrist or to in-patient services. Moreover, patients have the 
option of choosing their hospital as there is no catchment area and because the country is small. 
Finally, Belgium has a higher density of psychiatric beds (1.7 per 1000 inhabitants) giving 
patients plenty of freedom to choose. 
AIMS OF THE STUDY 
This study addresses socio-economic disparities in psychiatric in-patient care. With the help of 
the comprehensive Psychiatric Case Register introduced in Belgium in 1996, we seek to assess 
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Material and methods 
DATA 
Since 1996, all psychiatric admissions, treatments and discharges have been subject to 
mandatory registering in a unique format, the Minimum Psychiatric Summary (MPS). This 
psychiatric case register is a comprehensive record of all psychiatric in-patient activities 
covering admission, treatment and discharge (27). It is organized in 12 sections, containing 300 
items. It covers information on the five DSM-IV axes, socio-economic background, previous 
living arrangements, referral process, ward and hospital identification, psychological symptoms 
at the beginning and at the end of the treatment, functioning at the beginning and at the end of 
the stay, evaluations, treatments and medication delivered. Each hospital has an MPS 
administrator, who controls the quality of the data. Training of the administrators and quality 
control are provided by a supervisor belonging to one of the seven participating universities. 
In this study, we used the 166 839 discharges occurring in the 1997–98 period; we excluded 
episodes of Psychiatric Community Care (PCC) or in psychogeriatric wards (n ¼ 1971); all 
episodes having their principal diagnosis defined on the second DSM-IV axis were excluded (n ¼ 
17 674). After exclusion of missing values, we were left with 144 754 discharges, accounting for 
87% of total psychiatric discharges. 
DEFINITION OF VARIABLES 
Clinical status was assessed by the diagnosis on the five DSM-IV axes. The diagnoses on the first 
axis were divided into the following categories: substance-related disorders, mood disorders, 
schizophrenia and other psychotic disorders, dementia and other cognitive disorders, and 
others. The second axis disorders (presented as secondary diagnosis) were divided into 
personality disorders or mental retardation. In the third axis, the medical conditions were coded 
according to the ICD-9 and the number of somatic comorbidities was computed. For the fourth 
axis, we computed the number of psychosocial and environmental problems (28). The fifth axis 
is the Global Assessment and Functioning (GAF) scale, an instrument widely used to assess 
overall functioning on a continuum ranging from 1 to 100 (28). Lastly, the MPS used a scale of29 
items to register the presence of DSM-IV psychological symptoms such as suicide ideation, 
threats of auto-aggression, hostility, depressive mood, etc. We computed the number of 
symptoms.  
Socio-economic status was defined by combining educational status, occupational level and 
activity status. Each individual was given a score equal to his or her mean relative ranking on 
these three variables. Individuals were then divided into five groups of rather equivalent size. As 
ties are more likely to occur, these groups do not strictly correspond to quintiles. Such a 
composite index has been previously used in psychiatric epidemiology (29). It helps to carry out 
a stratification on the whole lifecycle, integrating both early educational achievement and 
ulterior professional mobility.  
Differences in psychiatric in-patient care were assessed for three main domains: admission 
setting, treatment received and the outcome of the stay. Five features indicating a less 
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favourable admission were considered: mode of admission (compulsory vs. voluntary), the 
hospital type (psychiatric hospital vs. general hospital with a psychiatric ward, non-teaching 
hospital vs. teaching hospital), hospital performance in terms of length of stay (long-stay 
hospitals vs. normal-stay hospitals) and, finally, the average severity of the patients cared for in 
the ward to which the patient is admitted (average GAF score of the ward). Hospital 
performance was estimated by the Bosmans and Fecher method (30). Those hospitals in the 
lower 15 percentile (out of132) were classified as hospitals with unexpectedly long length of 
stay (HULLS).  
For the three main groups of diagnosis, adequate treatments were defined according to current 
guidelines: antidepressants and psychotherapies for mood disorders, surveillance of withdrawal 
and relapse for substance-related disorders, and neuroleptic drugs for schizophrenic and other 
psychotic disorders (31). Four outcome variables were defined. The evolution of the GAF scale 
score (discharge score - admission score), the evolution in the number of psychological 
symptoms, readmission and in-hospital mortality rate. 
STATISTICAL ANALYSIS 
Generalized linear models (using GENMOD SAS procedure) were used to estimate the 
relationship between SES and the dependent variables. A logitlink function was used for the 
binary dependent variable (mode of admission, hospital type, treatment, readmission and 
mortality). All estimations were controlled for the five DSM-IV axis diagnoses, number of 
psychiatric and somatic comorbidities, number of psychological symptoms, previous psychiatric 
in-patient history, age and sex. Because the link between mental health and SES has been shown 
to be disorder-specific (32, 33), the risk factors are also presented for five main groups of 
mental disorders. 
Results 
Substance, mood and psychotic disorders accounted for three quarters of all discharges (see 
Table 1). Comorbidity was frequent, with more than one-third of the episodes having a 
personality disorder comorbidity, another axis-1 comorbidity as well as a somatic comorbidity. 
The most frequent diseases were epilepsy, diabetes, chronic liver cirrhosis, hypertension, 
obesity, cerebral degeneration and chronic bronchitis. On average, an episode presented 1.7 
psychosocial and environmental problems. Overall GAF reached a score of44 which is low 
compared with previous studies (34–38). A third of the patients discharged had a previous in-
patient psychiatric history. 
More than half of the episodes concerned adults between 35 and 64 years old. This was partly 
due to the exclusion of psychogeriatric wards, where most elderly patients are cared for. A small 
proportion of the episodes resulted from admission on a compulsory basis (11.9%). Discharges 
were divided equally among general hospitals with psychiatric wards and psychiatric hospitals, 
with a small proportion of the episodes being cared for in teaching hospitals or in HULLS. 
Between admission and discharge, the GAF score improved by 12.9 (effect size = 0.82) and the 
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number of psychological symptoms was reduced by 1.4 (effect size = -0.58). Readmission and 
mortality rates reached 34 and 0.8%, respectively. 
Table 1. Clinical, sociodemographic and setting distribution of psychiatric inpatients 
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The socio-economic risk factors of unfavourable admission features, unexpected treatment and 
outcome are set out in Table 2. Each coefficient is controlled for axis-1 group disorders, axis-2 
group disorders, number of psychiatric comorbidities, number of somatic comorbidities, number 
of psychosocial problems, admission GAF score, number of psychological symptoms, previous in-
patient psychiatric history, age and sex. As SES increased, there was a slight monotonic decrease 
in the likelihood of being admitted mandatorily [first quintile, odds ratio (OR) = 1.22]. Lower 
SES groups were more likely to be admitted to a nonteaching (OR = 1.17) or psychiatric hospital 
(OR = 1.47). Admission to HULLS also decreased with SES. A monotonic decreasing relationship 
was observed with respect to the overall functioning of patients in the ward: the higher the SES 
the better the mean GAF score of the ward where the patient was cared for. Hence, for most of 
the admission features, increasing SES was associated with more favourable circumstances.  
Unexpected care was linked to SES. Among patients with mood disorders, the lowest SES group 
was more likely not to receive antidepressant drugs (OR = 1.66) and psychotherapy (OR = 
1.51). Such under-provision decreased monotonically with SES. Among patients with substance 
abuse-related disorders, a slight under-provision of withdrawal surveillance was observed for 
the lowest SES group (OR = 1.10). There were few socio-economic differences regarding the 
provision of neurotic drugs for psychotic patients. 
Regarding outcome, there was a monotonically decreasing benefit from hospitalization as SES 
increased, with respect to GAF score and psychological symptoms. The lowest SES group 
improved its functioning to a lesser extent (β = -3.57) and was left with more residual 
symptoms (β = 0.22) when compared with the highest group. The readmission rate was greater 
in the second-lower socio-economic group (OR = 1.35). There was a significantly higher risk of 
mortality for the lowest SES group (OR = 1.79). Mortality did not, however, present a monotonic 
decreasing relationship with SES. 
The outcome differences were analysed further by groups of disorders (Table 3). In order to 
limit the number of coefficients, two SES groups were formed, dividing the sample into two 
groups of equal size. Again, all the results were controlled for the clinical and demographic 
variables presented previously. No unique ranking of the disorders was found. Considering GAF 
and the number of psychological symptoms, schizophrenia and substance disorders showed 
more unequal results, while affective disorders and dementia evidenced the least unequal 
distribution of outcome. Turning to readmission risk, the groups of disorders showed very 
similar socio-economic differences, except for dementia. The risk of mortality of the lower SES 
group was higher among the patients with substance-related disorders and other disorders. 
Using educational level instead of the composite indicators led to slight differences (results not 
shown). Regarding admission, differences were more marked for some variables (use of 
nonteaching hospitals, admission to HULLS, severity of the patients cared in the same ward and 
non-psychotherapies) and smaller for other variables (compulsory admission, psychiatric 
hospitals and no antidepressant drugs). Outcome discrepancies were generally smaller when 
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Table 2. Risk of less favourable admission, of unexpected treatment and of outcome for psychiatric 
inpatient care: odds ratios (OR) and β coefficient by socio-economic quintile 
 
 
OR: multivariate odds ratio; β: multivariate regression coefficient. Standard error of the estimate in parenthesis. 
Significance: * 0.05, ** 0.01, *** 0.001. Each coefficient is controlled for axis-1 group of disorders, axis-2 group of 
disorders, number of psychiatric comorbidities, number of somatic comorbidities, number of psychosocial problems, 
GAF score, number of psychological symptoms, previous psychiatric history, age and sex. 
Table 3. Socio-economic risk of less favourable outcome of psychiatric hospitalization by DSM groups: 
odds ratios and b coefficients of the lower 50 percentile compared with the higher 50 percentile 
 
OR: multivariate odds ratio; β: multivariate regression coefficient; standard error of the estimate in parenthesis. 
Significance: * 0.05, ** 0.01, *** 0.001. Each coefficient is controlled for axis-1 group of disorders, axis-2 group of 
disorders, number of psychiatric comorbidities, number of somatic comorbidities, number of psychosocial problems, 
GAF score, number of psychological symptoms, previous psychiatric history, age and sex. 
Discussion 
Our results show that psychiatric hospitalization is associated with socio-economic differences 
in terms of access to more favourable settings, adequate treatment and outcome. First, the 
likelihood of availing more favourable settings for in-patient mental care increased with SES: 
lower SES individuals were less likely to be admitted to a teaching or general hospital, and they 
had a higher likelihood of being admitted through compulsory admission, of finding themselves 
in a more severe case-mix ward, and of being cared for in HULLS. Secondly, lower SES groups 
with mood disorders received less psychotherapy and fewer antidepressant drugs. Thirdly, we 
found evidence that lower SES groups achieved less improvement in their functioning and 
psychological symptoms. This suggests that psychiatric hospitalization is associated with low to 
moderate inequalities in mental care and health.  
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The present study could be affected by three sources of bias, related to confounding, self-
selection and accuracy. Although this study counts with several clinical variables, we did not 
have a severity score. There is, hence, a risk that severity may confound the relationship 
between SES and admission setting, treatment or outcome. Previous studies have suggested that 
lower SES patients presented more severe symptoms, yielding a less favourable outcome. For 
two reasons we feel rather confident that our estimations would not be strongly affected. First, 
our results are controlled for functioning, which is linked to severity; secondly, the level of 
difference was similar when comparing severe major depression (296.23) with moderate 
(296.22) or mild major depression (296.21), or when comparing alcohol abuse (305.00) with 
alcohol dependence (303.9). However, in the absence of a validated score (such as an Hamilton), 
the role of severity cannot totally be ruled out. Other sources of confounding could alter our 
results. Help-seeking behaviour, referral patterns and financial barriers could influence the 
inequalities in access. It is well known that individuals of lower SES use more GP whereas higher 
SES individuals lay emphasis on speciality mental health care (8). Preferences for 
psychotherapeutic approach in the treatment of mental health might also explain that higher SES 
groups received more psychotherapies (39). Ethnicity – a variable not registered in the MPS – 
has also been shown to influence referral and help-seeking behaviour (40). Finally, family 
support, coping style and verbal IQ are other possible confounding factors that we do not count 
with. All these covariates might explain part of the socio-economic differences found in this 
study.  
Self-selection could arise in this study. Psychiatric hospitalization concerns only a small 
proportion (around 5%) of all psychiatric patients (41). Hence, the present findings cannot be 
extrapolated to all mental care, as they refer to more chronic, severe and comorbid disorders 
than those treated in ambulatory settings (41). Localization of the hospitals in urban centres 
could also favour a higher use by lower SES groups. However, it is unlikely that the SES gradient 
would be accounted for by the localization of hospitals. First, hospitals do not have catchment 
area and patients can roam freely between hospitals. Also, Belgium counts with a high density of 
psychiatric hospital within a small territory. Finally, most of the teaching hospitals or psychiatric 
wards of general hospitals are located in urban centres so that one type of hospital is not 
spatially more accessible than another type. Hence, we think that localization is  unlikely to be a 
strong determinant of the observed inequalities. 
A final self-selection issue stems from the lack of unique patient number, providing revolving-
door or chronic patients with more weights. As such patients are over-represented, there is a 
risk of a slight overestimation of the inequalities because chronic patients generally have a lower 
SES. Although we have been able to stifle out part of such confounding factors by controlling for 
previous psychiatric hospitalization, there is still a risk of a slight overestimation of the 
inequalities because chronicity is more likely to be underestimated. 
A final limitation of this study is due to the type of data used. This information is not registered 
by researchers and may lack accuracy, as has been shown by studies of discharge registers (42, 
43). Although the MPS has never been used to capitate resources for psychiatric hospitals, many 
clinicians in fact feared such a prospect, which may have led to over-scoring of patients. Indeed, 
when focusing on GAF scoring we found a small interaction effect between diagnosis on the first 
four DSM axes and hospital, implying that some hospitals tend to score a higher or lower GAF for 
Published in : Acta Psychiatrica Scandinavica (2003), vol. 107, n°3, pp. 170–177 
DOI:10.1034/j.1600-0447.2003.00071.x 




a given level on the first four DSM axes. Some previous studies have raised doubts about the 
validity and reliability of the GAF, particularly for measuring functioning (38). However, 
although any such unreliability may affect inter-hospital comparisons, it is unlikely to influence 
the socio-economic gradient observed in this study. Moreover, the GAF still belongs to the DSM-
IV multiaxial diagnosis and recent studies have shown that it performs well in comparison with 
alternative measures of functioning (44). Overall, the GAF appears to be reasonably valid, with 
moderate reliability (36, 45). 
Our results are consistent with previous studies addressing socio-economic inequalities in out-
patient care. A recent cross-national comparison study showed that higher socio-economic 
groups used more specialized care, while lower SES individuals used primary care providers (8, 
18). Evidence of treatment differences, for a given setting, is slight. A recent study has shown 
that depression recognition by GPs was dependent on sociodemographic correlates (46, 47). 
There is also some indication that better-educated individuals favour a psychotherapeutic 
approach, whereas those in lower educational groups have a more favourable opinion of the use 
of medication for mental health problems (48). Regarding outcome inequalities, this study is 
consistent with the Hampshire depression results. This project showed that, for a given baseline 
score, employment status as well as area-level of deprivation predicted both remission and 
improvement of depression at 6 weeks and 6 months (49).  
While most previous studies have focused on access to mental health care, our study suggests 
that differences do not apply only to access but also to treatment and outcome. In fact, 
differences in access are rather limited. The work done hints that socio-economic difference also 
arises in the way patients are cared for, once admitted in a psychiatric in-patient setting and in 
the outcome of psychiatric hospitalization.  
This may have important implications for the financing and delivery of mental care and for 
clinical practice. First, the study provides a double rationale for a review of the current financing 
scheme. The unequal allocation of resources by hospital type entails an unequal distribution of 
resources for patients with equal needs. As higher SES groups are more able to use better-
financed hospitals (teaching and general hospitals have better staff ⁄ bed ratios and drugs 
reimbursement), this implies that the current system promotes a regressive allocation of 
resources. This is particularly true for the new – and costly – atypical antipsychotic drugs (50): a 
patient admitted in better financed hospitals might be more likely to receive such drugs. 
However, even if hospital resource allocation were made according to clinical status, the 
resulting capitation system would still disregard the unequal capacity to the benefit of the lower 
socio-economic groups. As these groups exhibit not only a poorer health status but also a poorer 
prognosis, an allocation scheme based on ill-health status would still be less favourable to lower 
SES groups. In some countries, hospital resources are distributed according to the socio-
economic background of the population cared for, for a given clinical status (51). An explanation 
of SES within the allocation scheme would be one way of accounting for unequal ill-health status 
as well as unequal prognosis. Secondly, as this study has shown, achieving a better distribution 
of resources within the psychiatric in-patient setting will not eradicate differences. It is, thus, the 
delivery of psychiatric care as a whole that needs to be examined. Belgium has almost twice the 
average European supply of psychiatric beds (0.93 per 1000 inhabitants), with an emphasis on 
big psychiatric hospitals. This is not what the WHO has been advocating. Belgium is still far from 
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the WHO recommendations of integrating mental health within the general sector, scrapping big 
psychiatric hospitals and developing community mental health services (52). Finally, the under-
provision of psychotherapies to lower SES individuals in this in-patient setting can be a subject 
of worry. If psychotherapies are effective, then efforts should be developed to improve their 
clinical delivery to different SES groups. This issue should be given thorough attention by policy 
makers and clinicians in order to promote equal use of indicated treatment within psychiatric 
in-patient wards. Future research should also try to disentangle the demand-side factors (i.e. 
patient preferences, cognitive abilities, etc.) and supply side factors (patient ⁄ staff ratios, type of 
psychotherapies, financing rules and clinical bias) influencing differences in psychiatric in-
patient care. 
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